EDIT
Editas Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.23
+4.87%Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- -1.58x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -0.22x
- Net debt / EBITDA
- 2.37x
Liquidity & coverage
- Current ratio
- 3.19x
- Quick ratio
- 3.19x
- Cash ratio
- 3.09x
- Interest coverage
- -39.05x
- EBITDA / interest
- -33.39x
- Working capital
- $149.6M
Cash & dividend
- FCF / debt
- -7.77x
- Cash flow / debt
- -7.73x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026